{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-007366","form_type":"8-K","ticker":"ANIK","cik":"0000898437","company_name":"Anika Therapeutics, Inc.","filed_at":"2021-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.139553+00:00","generated_at":"2026-06-28T16:00:48.627346+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Anika Therapeutics appoints Sheryl Conley to Board of Directors; adds orthopedic industry expertise","bullets":["Appointed Sheryl Conley as independent director effective Oct 28, 2021; board expands from seven to eight members.","Ms. Conley brings over 35 years of orthopedic experience, including 25 years at Zimmer as Group President and CMO.","She will serve on the Audit Committee and received 8,179 restricted stock units vesting over three years.","Currently President of AcceLINX and board member at Neuronetics (STIM) and Surgalign (SRGA)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-007366","json":"https://secwatch.observer/filing/0001171843-21-007366.json","markdown":"https://secwatch.observer/filing/0001171843-21-007366.md","text":"https://secwatch.observer/filing/0001171843-21-007366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/0001171843-21-007366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/f8k_110121.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:00:48.627346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c3825f8d78","claim":"Sheryl L. Conley was elected as Director at Anika Therapeutics, Inc..","evidence_excerpt":"elected Sheryl L. Conley as a member of the Board effective as of October 28, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/0001171843-21-007366-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}